Professor Claude Wischik, CEO TauRx Therapeutics Ltd, Professor Bjoern Schelter CEO GT Diagnostics and TauRx Data Analytics and Biostatistics Lead, and Dr. Serge Gauthier, TauRx scientific advisory board chairman and director of the Alzheimer's Disease Research Unit, McGill Centre for Studies in Ageing, Quebec, Canada discuss the future of Alzheimer's disease diagnostics in primary care.
![](https://s2.save4k.ru/pic/9Dcu2hQ4nLs/maxresdefault.jpg)